abstract |
The present invention relates to a pharmaceutical composition comprising an alkali metal alginate, an alkali salt and less than 10% by weight of calcium salt based on the weight of the alkali metal alginate. This pharmaceutical composition is intended for the treatment or prevention of dyspepsia in mammals. [Selection] Figure 2 |